Next Article in Journal
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19
Next Article in Special Issue
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease
Previous Article in Journal
From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution
Previous Article in Special Issue
Pitfalls in the Application of Dispase-Based Keratinocyte Dissociation Assay for In Vitro Analysis of Pemphigus Vulgaris
 
 
Communication

Article Versions Notes

Vaccines 2022, 10(4), 549; https://doi.org/10.3390/vaccines10040549
Action Date Notes Link
article xml file uploaded 1 April 2022 11:22 CEST Original file -
article xml uploaded. 1 April 2022 11:22 CEST Update -
article pdf uploaded. 1 April 2022 11:22 CEST Version of Record -
article html file updated 1 April 2022 11:23 CEST Original file -
article xml file uploaded 1 April 2022 11:34 CEST Update -
article xml uploaded. 1 April 2022 11:34 CEST Update https://www.mdpi.com/2076-393X/10/4/549/xml
article pdf uploaded. 1 April 2022 11:34 CEST Updated version of record https://www.mdpi.com/2076-393X/10/4/549/pdf
article html file updated 1 April 2022 11:36 CEST Update -
article html file updated 2 August 2022 16:54 CEST Update https://www.mdpi.com/2076-393X/10/4/549/html
Back to TopTop